Evidence map›Paper›PMID 30586707›Full record

ArticleCirculation2019

Glycolytic Switch Is Required for Transdifferentiation to Endothelial Lineage.

Li Lai, Erin Reineke, Dale J Hamilton, John P Cooke

Open access · bronzeAbstract read
In one paragraph

Article in Circulation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Epigenetic Regulation of Angiogenesis in Peripheral Artery Disease.Methodist DeBakey cardiovascular journal · 2023
    Review
  17. Role of angiogenic transdifferentiation in vascular recovery.Frontiers in cardiovascular medicine · 2023
    Review
  18. Is Cardiovascular Regeneration Possible?Methodist DeBakey cardiovascular journal · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Li LaiDepartment of Cardiovascular Sciences, Center for Cardiovascular Regeneration (L.L., J.P.C.), Houston Methodist Research Institute, TX.
Erin ReinekeCenter for Bioenergetics (E.R., D.J.H.), Houston Methodist Research Institute, TX.
Dale J HamiltonCenter for Bioenergetics (E.R., D.J.H.), Houston Methodist Research Institute, TX.
John P CookeDepartment of Cardiovascular Sciences, Center for Cardiovascular Regeneration (L.L., J.P.C.), Houston Methodist Research Institute, TX.
BioEnergetics (United States) · USHouston Methodist · US

Funding

Basic and Translational Research iPSC-based hematologic and vascular therapiesU01HL100397 · NHLBI · STANFORD UNIVERSITY · PI COOKE, JOHN P · 2009 to 2015
$7.4M
Role of S-nitrosylation in TransdifferentiationR01HL133254 · NHLBI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI CHEN, KAIFU, COOKE, JOHN P · 2018 to 2021
$1.6M
NHLBI NIH HHS R01 HL133254NHLBI NIH HHS U01 HL100397
6 · The paper itself

Abstract

backgroundWe have previously shown that activation of cell-autonomous innate immune signaling facilitates the transdifferentiation of fibroblasts into induced endothelial cells, and is required to generate induced endothelial cells with high fidelity for endothelial lineage. Recent studies indicate that a glycolytic switch plays a role in induced pluripotent stem cell generation from somatic cells.

methodsSeahorse and metabolomics flux assays were used to measure the metabolic changes during transdifferentiation in vitro, and Matrigel plug assay was used to assess the effects of glycolysis modulators on transdifferentiation in vivo.

resultsThe metabolic switch begins rapidly after activation of innate immunity, before the expression of markers of endothelial lineage. Inhibiting glycolysis impaired, whereas facilitating glycolysis enhanced, the generation of induced endothelial cells. The toll-like receptor 3 agonist poly I:C increased expression of the mitochondrial citrate transporter Slc25A1, and the nuclear ATP-citrate lyase, in association with intracellular accumulation of citrate, the precursor for acetyl coenzyme A. These metabolic changes were coordinated with increased histone acetylation during transdifferentiation.

conclusionInnate immune signaling promotes a glycolytic switch that is required for transdifferentiation, both processes being attenuated by ATP-citrate lyase knockdown. These data shed light on a novel link between metabolism and epigenetic modulation in transdifferentiation.

Indexed as

Cell LineageCell TransdifferentiationGlycolysisAcetylationAnimalsATP Citrate (pro-S)-LyaseCells, CulturedCitric AcidEndothelial CellsEpigenesis, GeneticFibroblastsHistonesImmunity, InnateMice, Inbred NODMice, SCIDMitochondrial ProteinsATP Citrate (pro-S)-LyaseCitric AcidHistonesMitochondrial ProteinsOrganic Anion TransportersPoly I-CSlc25a1 protein, mouseTLR3 protein, mouseToll-Like Receptor 3cell transdifferentiationendotheliumglycolysismitochondria

Identifiers

PMID30586707
PMCPMC6311718
OpenAlexW2894347786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.